(Q33893535)

29 July 2017

title

High-dose chemotherapy for high-risk primary breast cancer: an on-site review of the Bezwoda study (English)

1 reference

29 July 2017

1 reference

R B Weiss

1

1 reference

29 July 2017

R M Rifkin

2

1 reference

29 July 2017

F M Stewart

3

1 reference

29 July 2017

R L Theriault

4

1 reference

29 July 2017

L A Williams

5

1 reference

29 July 2017

A A Herman

6

1 reference

29 July 2017

R A Beveridge

7

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 March 2000

1 reference

29 July 2017

1 reference

29 July 2017

volume

355

1 reference

29 July 2017

issue

9208

1 reference

29 July 2017

page(s)

999-1003

1 reference

High-dose combination alkylating agents with bone marrow support as initial treatment for metastatic breast cancer

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2990024-2

7 January 2021

Efficacy, toxicity, and applicability of high-dose sequential chemotherapy as adjuvant treatment in operable breast cancer with 10 or more involved axillary nodes: five-year results

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2990024-2

7 January 2021

High-dose chemotherapy and autologous bone marrow support as consolidation after standard-dose adjuvant therapy for high-risk primary breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2990024-2

7 January 2021

High-dose chemotherapy with autologous hematopoietic stem-cell support for breast cancer in North America

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2990024-2

7 January 2021

High-dose chemotherapy with hematopoietic rescue as primary treatment for metastatic breast cancer: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2990024-2

7 January 2021

Randomised trial of high-dose chemotherapy and haemopoietic progenitor-cell support in operable breast cancer with extensive axillary lymph-node involvement

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2990024-2

7 January 2021

Randomized trial of high-dose chemotherapy and blood cell autografts for high-risk primary breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2990024-2

7 January 2021

A successful system of scientific data audits for clinical trials. A report from the Cancer and Leukemia Group B.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2990024-2

7 January 2021

Handling of scientific dishonesty in the Nordic countries

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2990024-2

7 January 2021

Systems of protocol review, quality assurance, and data audit

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2990024-2

7 January 2021

10.1016/S0140-6736(00)90024-2

Identifiers

DOI

1 reference

release_pacecwsxf5bd3mkhpidih6r6ue

29 July 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/pacecwsxf5bd3mkhpidih6r6ue

24 November 2022

mapped directly with Wikidata item

1 reference